<![CDATA[Gynecologic Oncology Update]]>3dc83fbd-ced3-5945-ad91-6694fafb422aSat, 07 Mar 2026 14:00:38 +0000Captivate.fmDr. Neil Lovehttps://artwork.captivate.fm/aa2bde68-0d40-4e41-b73e-fff33f9524cf/gou-podcast-logo-3000px.pngGynecologic Oncology UpdateDr. Neil LoveDr. Neil LoveThis series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.https://www.researchtopractice.com/browse-tumor-types/ovarian-cancerfalseepisodichttps://feeds.captivate.fm/gynecologic-oncology/nopodcastOvarian Cancer — Year in Review Series on Relevant New Datasets and AdvancesOvarian Cancer — Year in Review Series on Relevant New Datasets and AdvancesProf Nicoletta Colombo and Dr Kathleen N Moore discuss the selection and sequencing of therapy for patients with ovarian cancer and summarize major advances in the treatment landscape over the past year.

CME information and select publications here.

]]>Prof Nicoletta Colombo and Dr Kathleen N Moore discuss the selection and sequencing of therapy for patients with ovarian cancer and summarize major advances in the treatment landscape over the past year.

CME information and select publications here.

]]>f50aac49-8a63-4534-879e-ee2d7108e232Sat, 07 Mar 2026 09:00:00 -050055:39falsefull24191924Gynecologic Cancers — Highlights from the 2025 ESMO Annual MeetingGynecologic Cancers — Highlights from the 2025 ESMO Annual MeetingDr Ritu Salani from the David Geffen School of Medicine at UCLA in Los Angeles, California, reviews datasets from ESMO Congress 2025 relevant to the care of patients with gynecologic cancers.

CME information and select publications here.

]]>Dr Ritu Salani from the David Geffen School of Medicine at UCLA in Los Angeles, California, reviews datasets from ESMO Congress 2025 relevant to the care of patients with gynecologic cancers.

CME information and select publications here.

]]>12c8d019-40d7-4590-aeb7-b0eb509522cfMon, 16 Feb 2026 08:00:00 -050057:09falsefull24181824Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N MooreAntibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N MooreDr Kathleen N Moore from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, discusses recent updates on available and novel treatment strategies with antibody-drug conjugates for ovarian cancer.

CME information and select publications here.

]]>Dr Kathleen N Moore from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, discusses recent updates on available and novel treatment strategies with antibody-drug conjugates for ovarian cancer.

CME information and select publications here.

]]>379d2bce-f4d9-4fe8-91a1-c12d3030594cMon, 09 Feb 2026 14:00:00 -050054:56falsefull24171724Ovarian Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology NetworkOvarian Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology NetworkDr Gottfried E Konecny from the University of California, Los Angeles, summarizes the treatment landscape and reviews relevant clinical datasets for patients with ovarian cancer. 

CME information and select publications here.

]]>Dr Gottfried E Konecny from the University of California, Los Angeles, summarizes the treatment landscape and reviews relevant clinical datasets for patients with ovarian cancer. 

CME information and select publications here.

]]>54f64772-d967-4fc2-8f1f-ddfee7c4f705Sat, 13 Dec 2025 10:30:00 -050048:48falsefull24161624Endometrial Cancer — Clinical Investigator Perspectives on Actual Patient CasesEndometrial Cancer — Clinical Investigator Perspectives on Actual Patient CasesDr Kathleen N Moore from OU Health Stephenson Cancer Center in Oklahoma City, Oklahoma, and Dr Matthew A Powell from the Washington University School of Medicine in St Louis, Missouri, discuss recent updates on available and novel treatment strategies for endometrial cancer. 

CME information and select publications here.

]]>Dr Kathleen N Moore from OU Health Stephenson Cancer Center in Oklahoma City, Oklahoma, and Dr Matthew A Powell from the Washington University School of Medicine in St Louis, Missouri, discuss recent updates on available and novel treatment strategies for endometrial cancer. 

CME information and select publications here.

]]>ad6d520b-ddf4-45e7-8691-653aa0f4e6a9Fri, 07 Nov 2025 14:00:00 -050001:00:17falsefull24151524Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management ParadigmOvarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management ParadigmDr Shannon Westin from the University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for ovarian and endometrial cancer.  

CME information and select publications here.

]]>Dr Shannon Westin from the University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for ovarian and endometrial cancer.  

CME information and select publications here.

]]>18cb37d3-31c0-480f-982d-16805908ae58Thu, 21 Aug 2025 11:00:00 -050052:35falsefull24141424Gynecologic Cancers — Year in Review Series on Relevant New Datasets and AdvancesGynecologic Cancers — Year in Review Series on Relevant New Datasets and AdvancesProf Susana Banerjee from The Institute of Cancer Research in London and Dr Ursula Matulonis from Dana-Farber Cancer Institute in Boston discuss important efficacy and safety data from the past year related to the management of ovarian, endometrial and cervical cancers.

CME information and select publications here.

]]>Prof Susana Banerjee from The Institute of Cancer Research in London and Dr Ursula Matulonis from Dana-Farber Cancer Institute in Boston discuss important efficacy and safety data from the past year related to the management of ovarian, endometrial and cervical cancers.

CME information and select publications here.

]]>0bcca8a9-1162-4411-8903-41686b5084b9Sat, 02 Aug 2025 08:00:00 -050059:34falsefull24131324Oncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New ApproachesOncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New ApproachesMs Jennifer Filipi from the Massachusetts General Hospital Cancer Center in Boston discusses nursing considerations for the treatment of ovarian cancer. 

NCPD information and select publications here.

]]>Ms Jennifer Filipi from the Massachusetts General Hospital Cancer Center in Boston discusses nursing considerations for the treatment of ovarian cancer. 

NCPD information and select publications here.

]]>862ba55e-41fe-4cc9-9f0d-c3c5ca71bc7dMon, 21 Jul 2025 09:00:00 -050053:51falsefull24121224Ovarian and Endometrial Cancer  — Proceedings from a Session Held During the 2025 ASCO Annual MeetingOvarian and Endometrial Cancer  — Proceedings from a Session Held During the 2025 ASCO Annual MeetingDrs Joyce F Liu, David M O’Malley, Ritu Salani, Alessandro D Santin and moderator Dr Shannon N Westin present data informing treatment decision-making for patients with advanced ovarian and endometrial cancers at the 2025 ASCO annual meeting. 

CME information and select publications here.

]]>Drs Joyce F Liu, David M O’Malley, Ritu Salani, Alessandro D Santin and moderator Dr Shannon N Westin present data informing treatment decision-making for patients with advanced ovarian and endometrial cancers at the 2025 ASCO annual meeting. 

CME information and select publications here.

]]>ce44b52e-ef81-4b6d-8704-fdc7c26f6bfdTue, 01 Jul 2025 14:00:00 -050001:59:45falsefull24111124For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS CongressFor Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS CongressDr David O’Malley and Dr Shannon Westin summarize the clinical treatment landscape for ovarian cancers, supported by clinical perspectives and management strategies from nurse practitioners Ms Courtney Arn and Ms Jennifer Filipi. 

NCPD information and select publications here.

]]>Dr David O’Malley and Dr Shannon Westin summarize the clinical treatment landscape for ovarian cancers, supported by clinical perspectives and management strategies from nurse practitioners Ms Courtney Arn and Ms Jennifer Filipi. 

NCPD information and select publications here.

]]>120b6f99-6bdd-4262-afac-60afa54dc3dfTue, 24 Jun 2025 14:00:00 -050001:31:27falsefull24101024For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS CongressFor Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS CongressDr Ritu Salani and Dr Brian Slomovitz and nurse practitioners Ms Kathryn Lyle and Ms Jaclyn Shaver discuss datasets guiding treatment decision-making for patients with endometrial cancer and strategies to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>Dr Ritu Salani and Dr Brian Slomovitz and nurse practitioners Ms Kathryn Lyle and Ms Jaclyn Shaver discuss datasets guiding treatment decision-making for patients with endometrial cancer and strategies to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>f0e95431-6a80-4303-9ae7-16e2e7d995ceFri, 06 Jun 2025 14:00:00 -050001:28:47falsefull249924Gynecologic Cancers — Fourth Annual National General Medical Oncology SummitGynecologic Cancers — Fourth Annual National General Medical Oncology SummitClinical investigators discuss available data guiding the management of gynecologic cancers.  

CME information and select publications here.

]]>Clinical investigators discuss available data guiding the management of gynecologic cancers.  

CME information and select publications here.

]]>f9d7c77a-63ac-4585-b0f5-12e153b7805aSun, 11 May 2025 09:00:00 -050048:41falsefull248824Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️Dr Kathleen Moore, Dr Ritu Salani, Dr Shannon Westin and moderator Dr Angeles Alvarez Secord share their perspectives and summarize recently presented data from the SGO 2025 annual meeting guiding the management of ovarian cancer. 

CME information and select publications here.

]]>Dr Kathleen Moore, Dr Ritu Salani, Dr Shannon Westin and moderator Dr Angeles Alvarez Secord share their perspectives and summarize recently presented data from the SGO 2025 annual meeting guiding the management of ovarian cancer. 

CME information and select publications here.

]]>ac9fc5e0-3bc6-4b86-b1d5-6c90d22ba3cbThu, 17 Apr 2025 16:00:00 -050001:29:33falsefull247724HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️Drs Kathleen N Moore and Alessandro D Santin and moderator Dr David M O’Malley summarize and share their perspectives on data guiding the management of HER2-positive gynecologic cancers that were presented at the Society of Gynecologic Oncology 2025 annual meeting. 

CME information and select publications here.

]]>Drs Kathleen N Moore and Alessandro D Santin and moderator Dr David M O’Malley summarize and share their perspectives on data guiding the management of HER2-positive gynecologic cancers that were presented at the Society of Gynecologic Oncology 2025 annual meeting. 

CME information and select publications here.

]]>9e900889-0ed0-45f0-8e44-dbb8448797c9Thu, 03 Apr 2025 09:00:00 -050001:29:21falsefull246624Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic CancersCases from the Community: Integrating New Research Findings into Current Practice — Gynecologic CancersDr Kathleen N Moore shares her perspectives on the evolving therapeutic landscape for patients with gynecologic cancers.

]]>Dr Kathleen N Moore shares her perspectives on the evolving therapeutic landscape for patients with gynecologic cancers.

]]>1bab4dcb-956b-4e87-a877-de95d4b04f0bTue, 17 Dec 2024 11:15:00 -050046:41falsefull245524Oncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial CancerOncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial CancerDr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers.

]]>Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers.

]]>F04D72D6-CD19-4632-8899-D65F2AC91ACBThu, 22 Aug 2024 12:14:00 -050052:37falsefull244424Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers.Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic OncologyYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic OncologyDr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers.

]]>Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers.

]]>D7ED58DB-C7C1-4A2A-BDE7-2FF471A1F173Fri, 26 Jul 2024 10:53:00 -050059:17falsefull243324Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers.Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part SeriesMeet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part SeriesDr Bradley J Monk from the Florida Cancer Specialists & Research Institute in West Palm Beach, Florida, discusses real-world patient cases and treatment strategies for ovarian cancer.

]]>Dr Bradley J Monk from the Florida Cancer Specialists & Research Institute in West Palm Beach, Florida, discusses real-world patient cases and treatment strategies for ovarian cancer.

]]>37EFFB09-3844-4DF2-859E-D64461540B85Fri, 16 Feb 2024 09:38:00 -050059:53falsefull242224Dr Bradley J Monk from the Florida Cancer Specialists & Research Institute in West Palm Beach, Florida, discusses real-world patient cases and treatment strategies for ovarian cancer.Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part SeriesMeet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part SeriesDr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid, Spain, discusses real-world patient cases and treatment strategies for ovarian cancer.

]]>Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid, Spain, discusses real-world patient cases and treatment strategies for ovarian cancer.

]]>0961BC1A-8E0A-48E7-AF17-8584C2ECA546Wed, 24 Jan 2024 09:33:00 -050001:01:37falsefull241124Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid, Spain, discusses real-world patient cases and treatment strategies for ovarian cancer.Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part EditionOncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part EditionDr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers.

]]>Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers.

]]>485D5F13-8960-4349-8D11-B6338BC25BC2Wed, 20 Dec 2023 11:22:00 -050001:05:36falsefull23111123Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers.Implications of Recent Data Sets for the Current and Future Management of Gynecologic CancersImplications of Recent Data Sets for the Current and Future Management of Gynecologic CancersDr Richard Penson from Massachusetts General Hospital in Boston, Massachusetts and Dr Krishnansu Tewari from the University of California, Irvine, discuss updated data from the 2023 ESMO Congress on optimal management approaches for gynecologic cancers.

]]>Dr Richard Penson from Massachusetts General Hospital in Boston, Massachusetts and Dr Krishnansu Tewari from the University of California, Irvine, discuss updated data from the 2023 ESMO Congress on optimal management approaches for gynecologic cancers.

]]>0A7E68DE-257F-4EAB-917F-FFBC6C57ACD6Tue, 21 Nov 2023 11:54:00 -050001:01:25falsefull23101023Dr Richard Penson from Massachusetts General Hospital in Boston, Massachusetts and Dr Krishnansu Tewari from the University of California, Irvine, discuss updated data from the 2023 ESMO Congress on optimal management approaches for gynecologic cancers.Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part SeriesMeet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part SeriesDr David M O’Malley from the Ohio State University and the James Cancer Center in Columbus, Ohio, discusses optimizing the management of ovarian cancer.

]]>Dr David M O’Malley from the Ohio State University and the James Cancer Center in Columbus, Ohio, discusses optimizing the management of ovarian cancer.

]]>4D85515F-BF20-49A8-9563-BCCF2FF5A002Thu, 02 Nov 2023 08:04:00 -050001:03:54falsefull239923Dr David M O’Malley from the Ohio State University and the James Cancer Center in Columbus, Ohio, discusses optimizing the management of ovarian cancer.Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part SeriesMeet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part SeriesDr Kathleen Moore from OU Health Stephenson Cancer Center in Oklahoma City discusses treatment decision-making for real-world cases and approved and investigational treatment strategies for the management of ovarian cancer.

]]>Dr Kathleen Moore from OU Health Stephenson Cancer Center in Oklahoma City discusses treatment decision-making for real-world cases and approved and investigational treatment strategies for the management of ovarian cancer.

]]>837C92C9-355C-48B2-8307-98C3D17DF060Tue, 10 Oct 2023 09:21:00 -050001:02:10falsefull238823Dr Kathleen Moore from OU Health Stephenson Cancer Center in Oklahoma City discusses treatment decision-making for real-world cases and approved and investigational treatment strategies for the management of ovarian cancer.Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian CancerOncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian CancerDr Debra L Richardson from OU Health Stephenson Cancer Center in Oklahoma City discusses novel agents and strategies for ovarian cancer.

]]>Dr Debra L Richardson from OU Health Stephenson Cancer Center in Oklahoma City discusses novel agents and strategies for ovarian cancer.

]]>7D08ACCA-5212-40FB-BAFD-F0BFCABA6778Tue, 26 Sep 2023 10:46:00 -050021:40falsefull237723Dr Debra L Richardson from OU Health Stephenson Cancer Center in Oklahoma City discusses novel agents and strategies for ovarian cancer.Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingOncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingFeaturing a discussion on recent updates in the management of gynecologic cancers from the ASCO 2023 Annual Meeting with Dr Floor Backes, moderated by Dr Neil Love.

]]>Featuring a discussion on recent updates in the management of gynecologic cancers from the ASCO 2023 Annual Meeting with Dr Floor Backes, moderated by Dr Neil Love.

]]>9028C835-6961-4DFA-B0AE-5E5F65239867Fri, 11 Aug 2023 12:50:00 -050043:12falsefull236623Featuring a discussion on recent updates in the management of gynecologic cancers from the ASCO 2023 Annual Meeting with Dr Floor Backes, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer IssueOncology Today with Dr Neil Love: Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer IssueDr David O’Malley from The James Cancer Center in Columbus, Ohio, discusses recent advances in the management of ovarian cancer, including presentations from ASCO 2023.

]]>Dr David O’Malley from The James Cancer Center in Columbus, Ohio, discusses recent advances in the management of ovarian cancer, including presentations from ASCO 2023.

]]>5968F134-5580-4352-B6D1-7EFDE9F26B21Fri, 04 Aug 2023 11:54:00 -050057:27falsefull235523Dr David O’Malley from The James Cancer Center in Columbus, Ohio, discusses recent advances in the management of ovarian cancer, including presentations from ASCO 2023.The Implications of New Research Findings for the Management of Endometrial CancerThe Implications of New Research Findings for the Management of Endometrial CancerFeaturing perspectives from Dr Bradley J Monk and Dr Matthew A Powell, moderated by Dr Neil Love.

]]>Featuring perspectives from Dr Bradley J Monk and Dr Matthew A Powell, moderated by Dr Neil Love.

]]>BF5C2571-B28C-4626-AF12-7E719D1A12FEFri, 14 Jul 2023 12:25:00 -050001:01:16falsefull234423Featuring perspectives from Dr Bradley J Monk and Dr Matthew A Powell, moderated by Dr Neil Love.Recent Advances and Future Directions in Gynecologic Cancers — With Dr Michael Birrer and Ursula Matulonis (Proceedings from a Symposium in Partnership with NCOA and SCOS)Recent Advances and Future Directions in Gynecologic Cancers — With Dr Michael Birrer and Ursula Matulonis (Proceedings from a Symposium in Partnership with NCOA and SCOS)Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.

]]>Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.

]]>D3CEEF76-6BA2-4ECD-94E0-EF61349ADBF1Fri, 17 Mar 2023 12:26:00 -050001:03:43falsefull233323Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.Oncology Today with Dr Neil Love: Management of Desmoid TumorsOncology Today with Dr Neil Love: Management of Desmoid TumorsFeaturing a discussion on the management of desmoid tumors with Dr Mrinal Gounder, moderated by Dr Neil Love.

]]>Featuring a discussion on the management of desmoid tumors with Dr Mrinal Gounder, moderated by Dr Neil Love.

]]>F6A04C55-C80D-461C-AECA-EC8AC3A37E3ETue, 28 Feb 2023 09:54:00 -050054:25falsefull232223Featuring a discussion on the management of desmoid tumors with Dr Mrinal Gounder, moderated by Dr Neil Love.Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic OncologyYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic OncologyProceedings from our Year in Review webinar on the management of gynecologic cancers. Featuring perspectives from Drs Michael Birrer and Kathleen Moore, moderated by Dr Neil Love.

]]>Proceedings from our Year in Review webinar on the management of gynecologic cancers. Featuring perspectives from Drs Michael Birrer and Kathleen Moore, moderated by Dr Neil Love.

]]>773E4D40-8146-4071-841C-122CAD7AA8B8Wed, 08 Feb 2023 09:33:00 -050001:03:53falsefull231123Proceedings from our Year in Review webinar on the management of gynecologic cancers. Featuring perspectives from Drs Michael Birrer and Kathleen Moore, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Role of PARP Inhibition in Ovarian CancerOncology Today with Dr Neil Love: Role of PARP Inhibition in Ovarian CancerFeaturing a discussion of the current role of PARP inhibitors in the care of patients with ovarian cancer with Dr Thomas Herzog, moderated by Dr Neil Love.

]]>Featuring a discussion of the current role of PARP inhibitors in the care of patients with ovarian cancer with Dr Thomas Herzog, moderated by Dr Neil Love.

]]>6341B430-8922-4A48-9223-71782C48EECAWed, 21 Dec 2022 07:15:00 -050050:06falsefull224422Featuring a discussion of the current role of PARP inhibitors in the care of patients with ovarian cancer with Dr Thomas Herzog, moderated by Dr Neil Love.Consensus or Controversy? Current and Future Management of Ovarian CancerConsensus or Controversy? Current and Future Management of Ovarian CancerFeaturing a discussion on the management of ovarian cancer with Drs Ursula Matulonis and Debra Richardson, moderated by Dr Neil Love.

]]>Featuring a discussion on the management of ovarian cancer with Drs Ursula Matulonis and Debra Richardson, moderated by Dr Neil Love.

]]>74AE3A63-638F-4366-B7E8-2E8B9D075CD3Wed, 30 Nov 2022 08:12:00 -050001:03:04falsefull223322Featuring a discussion on the management of ovarian cancer with Drs Ursula Matulonis and Debra Richardson, moderated by Dr Neil Love.The Clinical Implications of Key Recent Data Sets in Ovarian Cancer — With Dr David O’Malley (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)The Clinical Implications of Key Recent Data Sets in Ovarian Cancer — With Dr David O’Malley (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in ovarian cancer. Featuring perspectives from Dr David O’Malley, moderated by Dr Neil Love.

]]>Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in ovarian cancer. Featuring perspectives from Dr David O’Malley, moderated by Dr Neil Love.

]]>3D58CA7A-D8FC-4A3F-9B0B-FE1033F21F6CWed, 16 Nov 2022 12:03:00 -050023:43falsefull222222Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in ovarian cancer. Featuring perspectives from Dr David O’Malley, moderated by Dr Neil Love.The Clinical Implications of Key Recent Data Sets in Endometrial Cancer — With Dr Shannon Westin (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)The Clinical Implications of Key Recent Data Sets in Endometrial Cancer — With Dr Shannon Westin (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in endometrial cancer. Featuring perspectives from Dr Shannon Westin, moderated by Dr Neil Love.

]]>Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in endometrial cancer. Featuring perspectives from Dr Shannon Westin, moderated by Dr Neil Love.

]]>FC0B74A0-C903-4AB6-A642-A313278ABA96Wed, 16 Nov 2022 12:03:00 -050022:27falsefull221122Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in endometrial cancer. Featuring perspectives from Dr Shannon Westin, moderated by Dr Neil Love.